Lorenz Buser

657 total citations
14 papers, 200 citations indexed

About

Lorenz Buser is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Lorenz Buser has authored 14 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Lorenz Buser's work include Bladder and Urothelial Cancer Treatments (5 papers), Urinary and Genital Oncology Studies (3 papers) and Renal cell carcinoma treatment (2 papers). Lorenz Buser is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Urinary and Genital Oncology Studies (3 papers) and Renal cell carcinoma treatment (2 papers). Lorenz Buser collaborates with scholars based in Switzerland, Germany and Austria. Lorenz Buser's co-authors include Peter J. Wild, Cédric Poyet, Filip Roudnicky, Thomas Hermanns, Michael Detmar, Tullio Sulser, Daniel Eberli, Philipp Baumeister, Marian S. Wettstein and Vivianne I. Otto and has published in prestigious journals such as Scientific Reports, Radiology and American Journal Of Pathology.

In The Last Decade

Lorenz Buser

14 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorenz Buser Switzerland 8 84 52 33 31 29 14 200
Sonja Rothweiler Switzerland 7 61 0.7× 69 1.3× 20 0.6× 47 1.5× 17 0.6× 8 256
Laurence Servais Belgium 7 91 1.1× 54 1.0× 105 3.2× 28 0.9× 77 2.7× 10 256
Thorsten Dohrmann Germany 10 69 0.8× 135 2.6× 22 0.7× 83 2.7× 29 1.0× 23 304
L. Torres Spain 8 52 0.6× 44 0.8× 17 0.5× 17 0.5× 24 0.8× 16 187
Yuichi Mitsui Japan 5 92 1.1× 101 1.9× 8 0.2× 27 0.9× 33 1.1× 11 304
Tomokazu Hoshi Japan 5 78 0.9× 151 2.9× 21 0.6× 124 4.0× 39 1.3× 8 348
Kala Jayaram United States 4 80 1.0× 25 0.5× 26 0.8× 18 0.6× 10 0.3× 8 190
Jiannan Xu China 8 59 0.7× 44 0.8× 10 0.3× 23 0.7× 25 0.9× 22 184
Akihiro Ichikawa Japan 9 53 0.6× 50 1.0× 8 0.2× 40 1.3× 61 2.1× 22 248
Xinping Zhou China 8 92 1.1× 57 1.1× 4 0.1× 17 0.5× 27 0.9× 43 290

Countries citing papers authored by Lorenz Buser

Since Specialization
Citations

This map shows the geographic impact of Lorenz Buser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenz Buser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenz Buser more than expected).

Fields of papers citing papers by Lorenz Buser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenz Buser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenz Buser. The network helps show where Lorenz Buser may publish in the future.

Co-authorship network of co-authors of Lorenz Buser

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenz Buser. A scholar is included among the top collaborators of Lorenz Buser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenz Buser. Lorenz Buser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Meyer, Stefanie, Lorenz Buser, Sebastian Haferkamp, et al.. (2023). Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma. European Journal of Cancer. 182. 77–86. 7 indexed citations
2.
3.
Buser, Lorenz, Marian S. Wettstein, Daniel Eberli, et al.. (2022). Modified Immunoscore Improves Prediction of Survival Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer—A Retrospective Digital Pathology Study. Diagnostics. 12(6). 1360–1360. 3 indexed citations
4.
Roudnicky, Filip, Cédric Poyet, Lorenz Buser, et al.. (2020). Characterization of Tumor Blood Vasculature Expression of Human Invasive Bladder Cancer by Laser Capture Microdissection and Transcriptional Profiling. American Journal Of Pathology. 190(9). 1960–1970. 8 indexed citations
5.
Hutterer, Georg C., Florian Posch, Lorenz Buser, et al.. (2019). BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study. Urologic Oncology Seminars and Original Investigations. 37(7). 510–518. 2 indexed citations
6.
Erichsen, Lars, Foued Ghanjati, Cédric Poyet, et al.. (2018). Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis. Scientific Reports. 8(1). 3477–3477. 11 indexed citations
7.
May, Matthias, Maximilian Burger, Wolfgang Otto, et al.. (2017). p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. Urologic Oncology Seminars and Original Investigations. 36(3). 94.e15–94.e21. 7 indexed citations
8.
Roudnicky, Filip, Lothar C. Dieterich, Cédric Poyet, et al.. (2017). High expression of insulin receptor on tumour‐associated blood vessels in invasive bladder cancer predicts poor overall and progression‐free survival. The Journal of Pathology. 242(2). 193–205. 26 indexed citations
9.
Barthelmes, Daniel, et al.. (2016). Iris cyst in a child with Aicardi syndrome: a novel association. Journal of American Association for Pediatric Ophthalmology and Strabismus. 20(5). 451–452. 2 indexed citations
10.
Poyet, Cédric, Lorenz Buser, Filip Roudnicky, et al.. (2015). Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer. Journal of Clinical Pathology. 68(10). 819–824. 32 indexed citations
11.
Winklhofer, Sebastian, Verena Tischler, Fabian Morsbach, et al.. (2015). Diagnostic Accuracy of Quantitative and Qualitative Phase-Contrast Imaging for the ex Vivo Characterization of Human Coronary Atherosclerotic Plaques. Radiology. 277(1). 64–72. 12 indexed citations
12.
Wettstein, Marian S., Lorenz Buser, Thomas Hermanns, et al.. (2015). CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer. Disease Markers. 2015. 1–8. 34 indexed citations
13.
14.
Potocki, Mihael, Tobias Breidthardt, Tobias Reichlin, et al.. (2009). Midregional pro-Adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study. Critical Care. 13(4). R122–R122. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonja Rothweiler Breakdown of academic impact, for papers by Laurence Servais Breakdown of academic impact, for papers by Thorsten Dohrmann Breakdown of academic impact, for papers by L. Torres Breakdown of academic impact, for papers by Yuichi Mitsui Breakdown of academic impact, for papers by Tomokazu Hoshi Breakdown of academic impact, for papers by Kala Jayaram Breakdown of academic impact, for papers by Jiannan Xu Breakdown of academic impact, for papers by Akihiro Ichikawa Breakdown of academic impact, for papers by Xinping Zhou
Rankless by CCL
2026